Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Multimodal Peri- and Intraarticular Drug Injections in Total Knee Arthroplasty

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* patients at least 18 years of age~* scheduled for elective total knee arthroplasty~* ASA I-III~* signed written informed consent~Exclusion Criteria:~* age \< 18~* ASA \> III~* moderate or severe cardiac disease, bronchial asthma~* allergy against ropivacaine, ketorolac or morphine~* analgetic abuse~* pregnancy or nursing women~* severe psychiatric disease~* moderate to severe dementia

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- LIA IV (Type: EXPERIMENTAL): Local infiltration analgesia with ropivacaine and adrenaline and intravenous ketorolac and morphine
- LIA IA (Type: EXPERIMENTAL): Local infiltration analgesia with ropivacaine, adrenaline and ketorolac and morphine
- EDA (Type: ACTIVE_COMPARATOR): standard continuous epidural analgesia

Based on this trial design, predict the completion outcome and termination type (if applicable).